Kliphouse Kirsten Marie 4

What Happened

• Kirsten Marie Kliphouse, a director of Labcorp Holdings, had 897 Restricted Stock Units (RSUs) fully vest on February 11, 2026. The filing reports the conversion of those RSUs into 897 shares (derivative exercise/conversion) and a matching disposition of 897 shares at $0.00.
• No dollar value for the acquisition is reported on the Form 4; the disposition is recorded at $0.00. The filing does not state a cash sale or open-market transaction.

Key Details

• Transaction date: February 11, 2026; Form 4 filed February 13, 2026 (timely).
• Reported entries: conversion/exercise of derivative (M) — 897 shares acquired (price N/A); 897 shares disposed at $0.00 (derivative).
• Footnotes: F1 — each RSU converts to one common share; F2 — the RSUs vested in full on Feb 11, 2026; F3 — the 897 figure reflects the aggregate RSUs held by the reporting person.
• Shares owned after the transaction: not specified in the filing.

Context

• This is an RSU vesting event (award conversion), not an open-market purchase or sale driven by market timing. Filings that show both acquisition on vesting and a simultaneous disposition at $0.00 are commonly consistent with net settlement or share withholding to satisfy taxes, though the Form 4 here only states the vesting and conversion.
• Such award vestings are routine compensation events for insiders and do not, by themselves, indicate a buy or sell signal from the director.